Company: LENZ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100630
Chunk: 21

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 21
---
 approve or make recommendations to our board of directors regarding the compensation for our executive officers, including our chief executive officer; |

| • |     | review, approve and administer our employee benefit and equity incentive plans; |

| • |     | establish and review the compensation plans and programs of our employees, and ensure that they are consistent with our general compensation strategy; |

| • |     | make recommendations to our board of directors regarding non-employee director compensation; |

| • |     | monitor compliance with any stock ownership guidelines; and |

| • |     | approve or make recommendations to our board of directors regarding the creation or revision of any clawback policy. |

Our compensation committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of Nasdaq, available on our website at https://ir.lenz-tx.com/corporate-governance.Following the closing of the Merger through December 31, 2024, our compensation committee held two meetings. Nominating and Corporate Governance Committee The current members of our nominating and corporate governance committee are Jeff George, Kimberlee C. Drapkin, and Zach Scheiner, and Mr. George serves as the chair of the nominating and corporate governance committee. Our board of directors has determined that each of the members of our nominating and corporate governance committee satisfy the independence requirements of Nasdaq. -11-

The functions of our nominating and corporate governance committee include, among other things, the authority and responsibility to:

| • |     | review and assess and make recommendations to our board of directors regarding desired qualifications, expertise and characteristics sought of board members; |

| • |     | identify, evaluate, select or make recommendations to our board of directors regarding nominees for election to our board of directors; |

| • |     | develop policies and procedures for considering stockholder nominees for election to our board of directors; |

| • |     | review our succession planning process for our chief executive officer and any other members of our executive management team; |

| • |     | review and make recommendations to our board of directors regarding the composition, organization and governance of our board of directors and its committees; |

| • |     | review and make recommendations to our board of directors regarding our corporate governance guidelines and corporate governance framework; |

| • |     | oversee director orientation for new directors and continuing education for our directors; |

| • |     | oversee the evaluation of the performance of our board of directors and its committees; |

|